AprilBio Co (XKRX:397030) Net Change in Cash : ₩-3,240 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is AprilBio Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

AprilBio Co's Net Change in Cash for the three months ended in Dec. 2024 was ₩-622 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-3,240 Mil.

AprilBio Co Net Change in Cash Historical Data

The historical data trend for AprilBio Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AprilBio Co Net Change in Cash Chart

AprilBio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

3,514.61

14,244.99

-17,092.92

-697.33

-3,240.00

AprilBio Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial													523.92	-156.86	-671.12	-1,790.50	-621.52

AprilBio Co Net Change in Cash Calculation

AprilBio Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	21959.667	+	-22797.053	+	-2513.126	+	110.512
	=	-3,240

AprilBio Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 5955.483 + -4307.537 + -3134.117 + 864.651

= -622

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-3,240 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AprilBio Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of AprilBio Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

AprilBio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AprilBio Co Ltd (XKRX:397030) » Definitions » Net Change in Cash

Comparable Companies

XKRX:228760 XKRX:389650 XKRX:115180 XKRX:372320 XKRX:334970 XKRX:199800 XKRX:140610 XKRX:078160 XKRX:064550 XKRX:304360 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270

Traded in Other Exchanges

N/A

Address

1 Kangwon National University Road, B-602, College of Medical and Life Sciences, Kangwon National University, Gangwon Special Self-Governing Province, Chuncheon-si, KOR

Website

http://www.aprilbio.com

AprilBio Co Ltd is a bio company is developing biologis. It owns long acting protein medicine platform technology utilizing human FAB antobody parts that makes unusual combination to serum akbumin and EX 12 helper phase antibody library technology.

AprilBio Co Headlines

No Headlines